EUZ — Eckert & Ziegler Strahlen und Medizintechnik AG Share Price
Last trade - 00:00- €810.44m
- €787.12m
- €222.26m
- 74
- 14
- 46
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.21 | ||
| PEG Ratio (f) | 1.08 | ||
| EPS Growth (f) | 30.52% | ||
| Dividend Yield (f) | 1.28% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.63 | ||
| Price to Tang. Book | 6.63 | ||
| Price to Free Cashflow | 73.38 | ||
| Price to Sales | 3.35 | ||
| EV to EBITDA | 14.77 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.15% | ||
| Return on Equity | 12.43% | ||
| Operating Margin | 16.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 168.71 | 178.49 | 176.14 | 180.44 | 222.26 | 240 | 264.6 | 9.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +55.97 | +49.81 | -13.21 | +26.94 | +14.51 | -6.77 | +34.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Directors
- Wolfgang Maennig CSU (61)
- Andreas Eckert CMG (60)
- Helmut Grothe VSU (60)
- Claudia Goulart MGB
- Joseph Hathcock MGB
- Gunnar Mann MGB (53)
- Franklin Yeager MGB
- Harald Hasselmann EXB (51)
- Lutz Helmke EXB
- Edgar Loeffler IND (67)
- Frank Perschmann IND (67)
- Albert Rupprecht IND (52)
- Jutta Ludwig SUB (67)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- December 10th, 1997
- Public Since
- February 25th, 2008
- No. of Employees
- 1,062
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 20,812,426
- Address
- Robert-Roessle-Str.10, BERLIN, 13125
- Web
- https://www.ezag.com/
- Phone
- +49 309410840
- Contact
- Karolin Riehle
- Auditors
- BDO AG Wirtschaftsprufungsgesellschaft
Latest News for EUZ
Upcoming Events for EUZ
Q4 2023 Eckert & Ziegler Strahlen und Medizintechnik AG Earnings Release
Q1 2024 Eckert & Ziegler Strahlen und Medizintechnik AG Earnings Release
Similar to EUZ
FAQ
As of Today at 18:07 UTC, shares in Eckert & Ziegler Strahlen und Medizintechnik AG are trading at €38.94. This share price information is delayed by 15 minutes.
Shares in Eckert & Ziegler Strahlen und Medizintechnik AG last closed at €38.94 and the price had moved by -30.15% over the past 365 days. In terms of relative price strength the Eckert & Ziegler Strahlen und Medizintechnik AG share price has underperformed the FTSE Global All Cap Index by -33.21% over the past year.
The overall consensus recommendation for Eckert & Ziegler Strahlen und Medizintechnik AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Eckert & Ziegler Strahlen und Medizintechnik AG dividend yield is 1.28% based on the trailing twelve month period.
Last year, Eckert & Ziegler Strahlen und Medizintechnik AG paid a total dividend of €0.50, and it currently has a trailing dividend yield of 1.28%. We do not have any data on when Eckert & Ziegler Strahlen und Medizintechnik AG is to next pay dividends.
We do not have data on when Eckert & Ziegler Strahlen und Medizintechnik AG is to next pay dividends. The historic dividend yield on Eckert & Ziegler Strahlen und Medizintechnik AG shares is currently 1.28%.
To buy shares in Eckert & Ziegler Strahlen und Medizintechnik AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €38.94, shares in Eckert & Ziegler Strahlen und Medizintechnik AG had a market capitalisation of €810.44m.
Here are the trading details for Eckert & Ziegler Strahlen und Medizintechnik AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: EUZ
Based on an overall assessment of its quality, value and momentum Eckert & Ziegler Strahlen und Medizintechnik AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Eckert & Ziegler Strahlen und Medizintechnik AG is €62.00. That is 59.22% above the last closing price of €38.94.
Analysts covering Eckert & Ziegler Strahlen und Medizintechnik AG currently have a consensus Earnings Per Share (EPS) forecast of €1.18 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eckert & Ziegler Strahlen und Medizintechnik AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.38%.
As of the last closing price of €38.94, shares in Eckert & Ziegler Strahlen und Medizintechnik AG were trading -3.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Eckert & Ziegler Strahlen und Medizintechnik AG PE ratio based on its reported earnings over the past 12 months is 25.21. The shares last closed at €38.94.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Eckert & Ziegler Strahlen und Medizintechnik AG's management team is headed by:
- Wolfgang Maennig - CSU
- Andreas Eckert - CMG
- Helmut Grothe - VSU
- Claudia Goulart - MGB
- Joseph Hathcock - MGB
- Gunnar Mann - MGB
- Franklin Yeager - MGB
- Harald Hasselmann - EXB
- Lutz Helmke - EXB
- Edgar Loeffler - IND
- Frank Perschmann - IND
- Albert Rupprecht - IND
- Jutta Ludwig - SUB